LONDON, April 12, 2016 /PRNewswire/ -- Smith & Nephew (LSE:SN, NYSE: SNN), the global medical technology business, today announced that it has been awarded a group purchasing agreement for the Skin Integrity: Prevention, Healing and Support category with Premier, Inc. Effective April 1, 2016, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Smith & Nephew's Advanced Wound Care products, including the ALLEVYN™ family of hydrocellular foam dressings, SECURA™ skin care system and ACTICOAT™ silver-coated antimicrobial barrier dressings.
"Smith & Nephew is a leader in wound care and understands that patients with wounds face many challenges. We are uniquely positioned to provide wound care solutions through our portfolio of products, clinical education, and support across the continuum of care," said François Fournier, President, U.S. Commercial, Advanced Wound Management at Smith & Nephew. "This new agreement with Premier exemplifies our commitment to patients and healthcare providers to secure wider access to our technologies for more customers."
Premier is a leading healthcare improvement company, uniting an alliance of approximately 3,600 hospitals and 120,000 other providers to transform healthcare.
About Smith & Nephew Advanced Wound Management
Smith & Nephew's Advanced Wound Management division provides high quality products, medical education and services supporting initial wound bed preparation through to full wound closure, enabling better outcomes for patients and healthcare systems. As part of this portfolio, Smith & Nephew offers:
ACTICOAT silver-coated antimicrobial barrier dressings that may help clinicians take control of the risk of soft tissue and surgical site infections.
ALLEVYN LIFE hydrocellular foam dressings with a unique five-layer construction designed to both absorb fluids and redistribute pressure, making it an ideal tool for wound management and pressure ulcer prevention protocols.
SECURA proven, preventive skin care products formulated with high-quality ingredients that define the standard of care for prevention.
NO-STING SKIN PREP™ liquid film forming skin protectant which can be used on intact or damaged skin to help prevent moisture associated dermatitis, incontinence associated dermatitis, friction and adhesive trauma.
About Smith & Nephew
Smith & Nephew is a global medical technology business dedicated to helping healthcare professionals improve people's lives. With leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma & Extremities, Smith & Nephew has around 15,000 employees and a presence in more than 100 countries. Annual sales in 2015 were more than $4.6 billion. Smith & Nephew is a member of the FTSE100 (LSE:SN, NYSE: SNN).
This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith & Nephew, these factors include: economic and financial conditions in the markets we serve, especially those affecting health care providers, payers and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls or other problems with quality management systems or failure to comply with related regulations; litigation relating to patent or other claims; legal compliance risks and related investigative, remedial or enforcement actions; disruption to our supply chain or operations or those of our suppliers; competition for qualified personnel; strategic actions, including acquisitions and dispositions, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20-F, for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith & Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith & Nephew are qualified by this caution. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith & Nephew's expectations.
™ Trademark of Smith & Nephew. Certain marks registered US Patent and Trademark Office.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/smith--nephew-awarded-skin-integrity-prevention-healing-and-support-category-agreement-with-premier-inc-300249696.html
SOURCE Smith & Nephew